ArticleCureus2026
Burden of Infectious Diseases in Afghanistan in 1999 and 2023: Findings From the Global Burden of Disease 2023 Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Afghanistan faces a critical health challenge due to different diseases, including diseases caused by infectious diseases, worsened by the structural limitations typical pattern in low- and middle-income countries. This secondary analysis of modeled 2023 estimated assessed data to evaluate changes in Disability-Adjusted Life Years (DALYs), Years Lived With Disability (YLDs), and Years of Life Lost (YLLs) in Afghanistan in 1999 and 2023. We used multiple regression using SPSS Software Version 28 (IBM Corp., Armonk, NY), and the results revealed that the Afghan population has experienced a statistically significant improvement in health outcomes for diseases caused by infectious diseases, with reductions in DALYs (64.8%), YLDs (47.9%), and YLLs (65.0%). The results were consistent with those of neighboring countries, suggesting the effectiveness of access to health sector services. The decrease in the burden of infectious diseases in Afghanistan can be attributed to improved access to curative medicine services and proactive public health measures, such as vaccination programs, access to clean sanitation systems, and better health literacy. The result did not show statistically significant gender differences in YLLs, YLDs, or DALYs, which challenges the conventional understanding of gender-based health disparities in access to care. The sustainability of Afghanistan's health gains can be threatened if persistent political instability and critical gaps in medical infrastructure continue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.